ACE and colorectal cancer: A limitation of this finding is that the magnitude of the effect of ACE inhibition on colorectal cancer may be underestimated, since the effect of ACE inhibitors on lowering ACE levels is likely more potent than the genetic effect from the variants used here as proxies for ACE levels.